Aberrant Glycogen Synthase Kinase 3β Is Involved in Pancreatic Cancer Cell Invasion and Resistance to Therapy

• Ayako Kitano ,

  Contributed equally to this work with: Ayako Kitano, Takeo Shimasaki

  Affiliations Division of Translational and Clinical Oncology, Cancer Research Institute, Kanazawa University, Kanazawa, Japan, Department of Hospital Pharmacy, Graduate School of Medical Science, Kanazawa University, Kanazawa, Japan

  ⨯
• Takeo Shimasaki ,

  Contributed equally to this work with: Ayako Kitano, Takeo Shimasaki

  Affiliations Division of Translational and Clinical Oncology, Cancer Research Institute, Kanazawa University, Kanazawa, Japan, Department of Medical Oncology, Kanazawa Medical University, Uchinada, Ishikawa, Japan, Medical Research Institute, Kanazawa Medical University, Uchinada, Ishikawa, Japan

  ⨯
• Yuri Chikano,

  Affiliations Division of Translational and Clinical Oncology, Cancer Research Institute, Kanazawa University, Kanazawa, Japan, Department of Hospital Pharmacy, Graduate School of Medical Science, Kanazawa University, Kanazawa, Japan

  ⨯
• Mitsutoshi Nakada,

  Affiliation Department of Neurosurgery, Graduate School of Medical Science, Kanazawa University, Kanazawa, Japan

  ⨯
• Mayumi Hirose,

  Affiliation Division of Translational and Clinical Oncology, Cancer Research Institute, Kanazawa University, Kanazawa, Japan

  ⨯
• Tomomi Higashi,

  Affiliations Division of Translational and Clinical Oncology, Cancer Research Institute, Kanazawa University, Kanazawa, Japan, Department of Hygiene, Graduate School of Medical Science, Kanazawa University, Kanazawa, Japan

  ⨯
• Yasuhito Ishigaki,

  Affiliation Medical Research Institute, Kanazawa Medical University, Uchinada, Ishikawa, Japan

  ⨯
• Yoshio Endo,

  Affiliation Central Laboratory, Cancer Research Institute, Kanazawa University, Kanazawa, Japan

  ⨯
• Takahisa Takino,

  Affiliation Division of Molecular Virology and Oncology, Cancer Research Institute, Kanazawa University, Kanazawa, Japan

  ⨯
• Hiroshi Sato,

  Affiliation Division of Molecular Virology and Oncology, Cancer Research Institute, Kanazawa University, Kanazawa, Japan

  ⨯
• Yoshimichi Sai,

  Affiliation Department of Hospital Pharmacy, Graduate School of Medical Science, Kanazawa University, Kanazawa, Japan

  ⨯
• Ken-ichi Miyamoto,

  Affiliation Department of Hospital Pharmacy, Graduate School of Medical Science, Kanazawa University, Kanazawa, Japan

  ⨯
• Yoshiharu Motoo,

  Affiliation Department of Medical Oncology, Kanazawa Medical University, Uchinada, Ishikawa, Japan

  ⨯
• Kazuyuki Kawakami,

  Affiliation Division of Translational and Clinical Oncology, Cancer Research Institute, Kanazawa University, Kanazawa, Japan

  ⨯
• Toshinari Minamoto

  * E-mail: minamoto@staff.kanazawa-u.ac.jp

  Affiliation Division of Translational and Clinical Oncology, Cancer Research Institute, Kanazawa University, Kanazawa, Japan

  ⨯